Adagio Medical Holdings (ADGM) Net Cash Flow (2023 - 2026)

Adagio Medical Holdings has disclosed Net Cash Flow across 4 years of filings, most recently posting -$5.3 million for Q2 2026.

• In Q2 2026, Net Cash Flow fell 12.36% year-over-year to -$5.3 million; the TTM figure through Jun 2026 stood at -$17.7 million (down 25.29% YoY), while the FY2025 annual figure was -$3.3 million, up 77.94% from the prior year.
• Net Cash Flow came in at -$5.3 million for Q2 2026 at Adagio Medical Holdings, down from -$4.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $5.1 million in Q2 2024 to a low of -$7.5 million in Q1 2025.
• Average Net Cash Flow over 4 years is -$2.8 million, with a median of -$4.1 million recorded in 2026.
• Year-over-year, Net Cash Flow sank 382.62% in 2025 and soared 45.3% in 2026.
• Over 4 years, Net Cash Flow stood at -$542000.0 in 2023, then sank by 1187.45% to -$7.0 million in 2024, then jumped by 48.08% to -$3.6 million in 2025, then sank by 45.74% to -$5.3 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$5.3 million in Q2 2026, -$4.1 million in Q1 2026, and -$3.6 million in Q4 2025.